Purpose: To explore predictors for short-and long-term prognosis of newly diagnosed epilepsy. Methods: 549 consecutive patients with newly diagnosed epilepsy were reviewed, 336 were enrolled in the study. Two-year remission in the short term (5 years) and five-year remission in the long term (>5, up to 8 years) were assessed as the outcomes. Logistic regression was used to identify independent predictors for unfavorable outcomes. x 2 test was used to compare the retention rates of old and new antiepileptic drugs (AEDs). Results: 185 patients (55%) attained two-year remission in the short term, 163 (48.5%) attained terminal remission in the long term. The time interval between index seizure and AED start >12 months implied an unfavorable outcome in the short term (OR = 1.9, p = 0.03). Two or more seizures in the first year after AED start showed the strongest negative prognostic impact in the both short-and long-term outcomes (OR = 2.3, p = 0.02; OR = 1.9, p = 0.03). As the seizure frequency rose, the possibility for unfavorable outcome increased. The terminal retention rates of traditional and new AEDs were not significantly different (p = 0.07). Conclusions: For patients with newly diagnosed epilepsy, the time interval between index seizure and AED start only influences the short-term outcome. Number of seizures in the first year after AED start is associated with both short-and long-term outcomes. It's imperative to initiate adequate, tolerated and appropriately chosen AED schedules after the definitive diagnosis of epilepsy.
Introduction
As one of the most prevalent chronic neurological condition characterized by the recurrence of unprovoked seizures, epilepsy is afflicting seventy million people worldwide, with 50.4 per 100,000 people newly diagnosed every year [1] . In clinical practice, the final goal of epilepsy management is to help patients attain complete seizure freedom with the minimal side effects of antiepileptic drugs (AEDs) [2] . Previous studies have indicated that the high frequency of seizures before appropriate AEDs therapy, poor response to initial AEDs therapy, specific epilepsy syndromes might suggest a worse outcome [3] [4] [5] . However, early predictors for short-and long-term outcomes of newly diagnosed epilepsy, which are crucial to guide timely AEDs therapy, are still partially unsettled.
Based on a pre-set epilepsy database, we conducted a retrospective study to explore potential risk factors associated with the short-and long-term prognosis of newly diagnosed epilepsy. The retention status of AEDs at the end of follow-up was also presented in the study.
Methods

Patients and setting
This retrospective cohort study is based on the detailed documentations in the database of the epilepsy clinic in the Xijing Hospital, a tertiary academic medical care center and one of the largest hospitals in western China. Between January 2008 and December 2010, 549 consecutive outpatients with newly diagnosed epilepsy and without histories of AEDs intake before the first appointment were reviewed. Epilepsy and epileptic seizure are defined according to the consensus carried out by The International League Against Epilepsy (ILAE) in 2014 [6] . The etiologies of epilepsy were classified into three categories idiopathic, symptomatic, or cryptogenic. The patients with symptomatic epilepsy were further grouped into: central nervous system (CNS) infection, traumatic brain injury, cortical dysplasia, vascular, and others (etiologies other than those above mentioned were classified as "others"). All the patients in the study were diagnosed and treated by the same neurologist. This study was approved by the ethics committee of the Xijing Hospital and was carried out in agreement with Chinese laws and the Declaration of Helsinki. All subjects participating in the study provided informed consent.
Variables
After each patient's appointment, trained research assistants entered all the pertinent data into an electronic database. Based on this pre-set epilepsy database, the following data were collected: demographic and clinical characteristics, seizure history, AED medications and seizure trajectories, side effects, and assistant examination results. The time interval between index seizure and AEDs start was evaluated and categorized into four groups: 0-6 months, 6-12 months, 12-60 months and >60 months. Index seizure was defined as the seizure that caused the patient to be registered in this study, which resulted in the diagnosis being made. The seizure frequency before the first appointment was defined as mean seizure density in one year before the first appointment. The number of seizures in the first year after AEDs start were recorded and stratified into 3 categories (0-1; 2-5; >5). Status epilepticus was defined as continuous seizure activity or not regaining consciousness between seizures for at least 5 min [7] . A continuous video-EEG (!15 h) was performed in each patient before initiating AED therapy. EEG characteristics were dichotomized into epileptiform activity (spikes, sharp waves, or spikewave complexes) and absent epileptiform activity (normal EEG or slow waves). Neuroimaging examinations (MRI or CI) performed on admission and within one year after admission were collected, and the worst results were recorded. According to whether the abnormality potentially induces seizures or not, neuroimaging characteristics were dichotomized into two groups.
Outcome assessment
A median follow-up of 6.0 years (IQR, 5.3-7.6) was performed in 549 patients and ended on December 31, 2015. Patients with poor compliance were excluded. A PDC (proportion of days covered) <0.80 was considered as poor compliance [8] . Short-term (5 years) and long-term outcomes (>5 years up 8 years) were assessed based on the data recorded in the epilepsy database and telephone interview by a trained research assistant who was blinded to the clinical data entered during the first year of initial AED therapy. Outcomes were assessed according to whether 2-year remission was attained in the short term and whether 5-year remission was attained in the long term.
AED medication investigation
The main reasons for the treatment failure (withdrawal of the initial AED, added or replaced by another AED) were explored from the following aspects: lack of efficacy (LE), adverse events (AEs), and others (pregnancy, poor economic conditions, non-compliance). Retention rates of traditional and new AEDs were calculated at the end of follow-up. According to the chronological introduction order of those AEDs in China, we grouped valproic acid (VPA), carbamazepine (CBZ), phenytoin (PHT) and phenobarbitone (PB) as old AEDs, which were introduced to Chinese market before 
Statistical analysis
Continuous variables were presented as mean AE standard deviation (normally distributed), as median and interquartile ranges (IQR, not normally distributed). Univariate and multivariate logistic regressions were used to screen and examine potential risk factors associated with the unfavorable outcome of newly 
Results
Demographic and clinical data
Among 549 consecutive out-patients with newly diagnosed epilepsy between January 2008 and December 2012, 81 patients with poor compliance to AED therapy, 79 lost in the follow-up, and 53 patients with incomplete information were excluded (Fig. 1) . A total of 336 patients were enrolled into the study, with the median age of 11 years (IQR 7, 17) at onset of index seizure. Among them, 58.3% were male, 72% were under 16 years old, and 52.4% had focal seizures. Detailed demographic and clinical characteristics were presented in Table 1 . All the patients had EEG examinations before starting the AEDs therapy. Patterns of epileptiform activities (spikes, sharp waves, or spike-wave complexes) were detected in 47% of all the patients in total. Among those 80 epilepsy patients with symptomatic etiologies, cortical dsyplasia and central nervous system infection were the most causes.
Seizure outcome
In the whole cohort of 336 patients, 252 (75%) of the study subjects remained seizure-free for at least one year, 43 (12.8%) patients developed drug resistant epilepsy. In the short term (5 years), 185 patients (55%) attained 2-year remission; in the long term (>5 years up 8 years), 163 (48.5%) achieved terminal remission (5-year). At the end of follow-up, among all the patients with Table 1 Demographic and clinical characteristics of the study population (N = 336).
Total (n, n/N%)
Short-term outcome Long-term outcome terminal remission, 105 (64.4%) were on AEDs, and 58 (35.6%) were off AEDs.
Predictors for short-and long-term outcomes
The determinants for short-and long-term outcomes of newly diagnosed epilepsy were manifested in Table 2 . Univariate analysis indicated that the chance of attaining 2-year and 5-year remission significantly decreased as the number of seizures in the first year after AED start and the time interval between index seizure and AED start increased. Patients with more than one seizure types were less likely to achieve 5-year remission (OR = 1.8, p = 0.02). Multivariate analysis confirmed the overall influence of the number of seizures in the first year after AED start on both shortand long-term outcomes of newly diagnosed epilepsy. The time interval between index seizure and AED start > 12 months is independently associated with only short-term outcome (OR = 1.9, p = 0.03), and as it lasted up to more than 60 months, the likelihood of unfavorable outcome got even greater (OR = 2.8, p = 0.02). However, to be noted, the study did not indicate that the time interval between index seizure and AED start will eventually influence the long-term outcome. Multivariate logistic regression analysis also suggested that when patients had two or more seizures in the first year after AED start, they had significantly less likelihood to attain 2-year remission (OR = 2.3; 95% CI, 1.2-4.4, p = 0.02) in the short term and 5-year remission in the long term (OR = 1.9; 95% CI, 1.1-3.5; p = 0.03). As the number of seizures increased to more than 5, the chance for unfavorable outcome in the short term (OR = 3.2; 95% CI, 1.2-7.8; p = 0.01) and in the long term (OR = 3.9; 95% CI, 1.9-8.1; p = 0.001) got greater. By logistic regression analyzing, more than one seizure types was suggested to have no independent association with the long-term outcome (p = 0.14).
AED medication
All study subjects were treated with adequate and appropriate AEDs after initial diagnosis. As Table 3 presented, at the end of follow-up, no significant difference of the retention rates between traditional and new AEDs was found among the patients who achieved or failed 5-year remission (p = 0.07). Also, no significant reasons (lack of efficacy, AEs, or others) were identified to be the leading cause of treatment failure between traditional AEDs and new AEDs (p = 0.1) ( Table 3 ). The retention rate of each AED in the cohort was presented in Table 4 . A total of 244 (72.6%) patients were still taking AEDs at the end of follow-up: 167 (49.7%) were under mono-therapy, and 77 (22.9%) were under multi-therapy. Significantly more patients who failed 5-year remission were found in the patients under AED multi-therapy (p < 0.01). Among the patients who were off AEDs, there were more patients who attained terminal remission (p < 0.01). Besides, no specific AED was found to have significant influence on remission. The two most commonly used AEDs in mono-or multi-therapy were VPA (n = 85, 29% of those still on AEDs therapy) and CBZ (n = 71, 24%) ( Table 3) . During the follow-up, AED withdrawal had been taken in 92 (27.4%) patients, and 34 (36.9%) of them had seizure relapse. The median time between withdrawal and relapse was 6 months (IOR, 5.5-11.3).
Discussion
Of many different seizure types, epilepsy is one of the most prevalent chronic neurological condition. Fortunately, most patients with newly diagnosed epilepsy are able to attain seizure control with AEDs therapy [9, 10] and 60% managed to have seizure freedom even after withdrawal of AEDs [11] . By analyzing the data collected in this cohort study (n = 336) with a median follow-up of 6 years, the time interval between index seizure and AED start was indicated to have a negative prognostic impact on short-term outcome, while it did not influence long-term outcome. Two or more seizures in the first year after AED start was identified to be the independent risk factor for both short-and long-term outcomes. No significant difference of retention rate was found between traditional and new AEDs.
Outcome of epilepsy
75% of patients with newly diagnosed epilepsy in the study had 1-year remission, which is similar to previous studies [12] [13] [14] . 55% of patients attained 2-year remission in the short term (5 years), which is less than the result of the study conducted by Del, F. A et al. [15] . This discrepancy might be due to the limitation of sample size and single setting in both studies. In the present study, 48.5% patients eventually achieved terminal remission (5-year) after a median follow-up of 6 years, which is similar to the study with longer follow-up done by Brodie et al. [12] , with a terminal remission rate of 59% after a median follow-up of 7.5 years.
Predictors for short-and long-term outcomes of newly diagnosed epilepsy
The time interval between index seizure and AED start was indicated to be the independent risk factor only for the short-term outcome, but it did not play a role in the long-term outcome, which is also shown in prior studies [16] [17] [18] . This finding suggested that the time interval between index seizure and AED start might not be associated with the intrinsic nature of drug-resistant epilepsy. Besides, the time interval between index seizure and AED start in our study is quite long (median, 26.4 months; IQR, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] , partially due to the extensive presence of treatment gap in low-income countries [19] .
As for the seizure frequency in the first year after AED start, the study identified its prominent role in both short-and long-term outcomes. Patients with !2 seizures in the first year after AED start have significantly greater likelihood to fail terminal remission (5-year). Another research also addressed this problem: after a 6-year follow-up, 65% of patients without seizure in the first year after AED start attained 5-year remission, only 6% of patients with !1 seizure reached 5-year remission [20] . What's more, as the number of seizures in the first year after AED start climbed up to ! 5, the possibility for unfavorable long-term outcome rose as well, which suggests that it's imperative to initiate adequate, tolerated and appropriately chosen AED schedules after the definitive diagnosis of epilepsy. Further auxiliary examinations, cautious reevaluation and differentiation are justified to guide more tailored therapy for patients with poor seizure control.
Although, symptomatic etiology was indicated to be an independent predictor of remission in other studies [21, 22] , no adequate evidence was shown in our study to confirm it. It maybe because that the etiology of the common epilepsy usually is a biological continuum combining genetic with acquired factors. The current etiology classification is too general to reflect individualized situations. Besides, age at index seizure onset, history of febrile seizure, family history of seizure, seizure density before diagnosis, number of seizure types, history of status epilepticus, seizure types, EEG and neuroimaging findings were not identified in the study to be the independent risk factors for the short-and long-term outcomes of newly diagnosed epilepsy. Further studies of a larger sample size and multi-center setting are needed to confirm it.
AEDs treatment
New AEDs have been reported in several studies to possess increased tolerability [23] . In our study, no significant difference of retention rate was found between traditional and new AEDs at the end of follow-up, but a trend that retention rate of new AEDs in patients who attained 5-year remission is higher was perceivable (p = 0.07). A larger sample size is needed to elucidate it. Meanwhile, the treatment cost is one of the major considerations for patients to select AEDs. A study conducted by Hong L et al. showed that the general medical care cost of epilepsy was about 372 USD per year for each patient, of which AEDs accounted for the major cost (243 USD). In addition, new AEDs were usually cost much more than traditional AEDs [24] . Whereas no significant difference of retention rate was found between traditional and new AEDs in the patients who achieved 5-year remission, traditional AEDs can be considered for patients who are not well-off, given the much lower price of it. Traditional AEDs combined with health education and constant follow-up under the guidance of well-trained physicians also might lead to satisfied outcomes [25] . At the end of follow-up, about 72.6% (n = 244) of the subjects were still on AEDs, and 68.4% were on mono-therapy. According to the study performed by Schmidt D [26] , 60.0% of all treated patients who have attained terminal remission were off AEDs. In our study, only 40.0% (n = 65) of the patients with terminal-remission were off AEDs. It's probably due to patients' worry about seizure relapse after AEDs withdrawal. What's more, 15.6% (n = 27) of the patients without terminal remission dropped AEDs due to poor compliance or economic situation. In the study, VPA was most frequently prescribed, followed by LEV and LTG, which showed a good consistency with the evidence review made by the international league against epilepsy (ILAE) [27] . Besides, seven patients (2.9%) without taking any AEDs in the last visit were receiving the traditional Chinese medicine therapy, and four of them did not attain terminal remission.
Limitations of study
A limited sample size of the study might not be fully capable of identifying all the potential independent risk factors for outcomes. Besides, the study population was mainly constituted by patients who had index seizure under 16 years old, which might lead to a representativeness bias. Further prospective, multicenter studies with lager population are needed to provide more reliable and sufficient evidence.
Conclusions
For patients with newly diagnosed epilepsy, the time interval between index seizure and AED start was significantly associated with short-term outcome, while it did not influence long-term outcome. The number of seizures !2 in the first year after AED start is the independent risk factor for both short-and long-term outcomes. It's imperative to initiate adequate, tolerated and appropriately chosen AED schedules after the definitive diagnosis of epilepsy. Moreover, given that no significant difference of retention rate was found between the traditional and new AEDs, it's reasonable to take consideration of patients' economic situations while selecting AEDs.
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